A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial
Open Access
- 28 February 2005
- journal article
- clinical trial
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 41 (3), 398-403
- https://doi.org/10.1016/j.ejca.2004.10.026
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR studyAnnals Of Oncology, 2004
- A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinomaAnnals Of Oncology, 2002
- Optimization of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of leucovorin, 5-FU and cisplatin (LV5FU2-P regimen) in patients with biliary tract carcinomaAnnals Of Oncology, 2002
- A phase II study of gemcitabine in gallbladder carcinomaAnnals Of Oncology, 2001
- Octreotide for Cancer of the Liver and Biliary TreeChemotherapy, 2001
- Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trialThe Lancet, 2000
- Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatinAnnals Of Oncology, 1998
- Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancerAnnals Of Oncology, 1996
- Comparison of 5-Fluorouracil, Doxorubicin and Mitomycin C with 5-Fluorouracil Alone in the Treatment of Pancreatic-Biliary CarcinomasOncology, 1994
- A Phase II Study of Cisplatin in Patients with Biliary Tract CarcinomaOncology, 1994